Skip to main content
CB

Core Biogenesis

Core Biogenesis utilizes proprietary plant-based bioproduction technologies to manufacture animal-free, endotoxin-free recombinant growth factors and cytokines for cell culture applications. This approach enhances the consistency and reproducibility of cell cultures, addressing the critical issue of endotoxin contamination in biomanufacturing processes.

Paris, FranceFounded 2020335K+ followers
Updated 20 months ago

Funding

$26.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

AEF+1
Funding rounds are not available yet.

Founders

Product

Problem

Cell cultures used in biomanufacturing are susceptible to endotoxin contamination, which can compromise consistency and reproducibility, particularly in sensitive applications like stem cell research and regenerative medicine. Traditional methods of producing growth factors often rely on animal components, introducing further variability and potential biorisk.

Solution

Core Biogenesis leverages a plant-based bioproduction platform to manufacture animal-free and endotoxin-free recombinant growth factors and cytokines. Their proprietary technology simplifies the mass production and purification of these recombinant molecules, offering a sustainable and cost-effective alternative to conventional methods. By using plants as biofactories and isolating molecules to specific plant compartments, Core Biogenesis enhances the consistency and scalability of cell cultures, facilitating the transition to clinical applications. Core Factors®, their line of recombinant growth factors, are enriched with purified plant lipids to improve bioavailability and stability.

Target Audience

The primary target audience includes researchers and manufacturers in cell therapy, regenerative medicine, and biopharmaceutical industries who require consistent, animal-free, and endotoxin-free growth factors for cell culture applications.

Features

  • Animal-free and endotoxin-free recombinant growth factors and cytokines
  • Proprietary plant-based bioproduction platform
  • Yield-boosting technology for efficient mass production
  • Specialized extraction methods for faster and more scalable purification
  • Core Factors® enriched with purified plant lipids for improved bioavailability and stability
  • Products designed for 3D cell culture, large-scale cell culture, and suspension cell culture
  • cGMP-grade FGF-2 TOP® (Thermostability Optimized) available
This profile is AI-generated and may contain inaccuracies.